NmVac4-A/C/Y/W-135-DT

· JN-International Medical Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NmVac4-A/C/Y/W-135-DT, covering 2016-04-12 to 2016-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study